View from Brussels

Sep 01, 2018
Applied Clinical Trials
Peter O’Donnell gauges the impact of FDA guidance on igniting the adaptive pathways debate in Europe.
Jul 01, 2018
Applied Clinical Trials
Recent developments offer more clues to the EU’s seemingly less-than-serious approach to health policy formation.
Jun 01, 2018
Applied Clinical Trials
Peter O’Donnell explores the convergence of policy and science in new vaccine R&D pursuits in Europe.
Apr 01, 2018
Applied Clinical Trials
Relocating the European Medicines Agency was always going to be hard—but no-one ever expected it to degenerate into farce.
Mar 01, 2018
Applied Clinical Trials
Peter O’Donnell weighs the varying views in Europe on the risks of going the adaptive pathways route for drug approval.
Feb 01, 2018
Applied Clinical Trials
Peter O’Donnell looks at efforts in Europe to improve R&D communication and trust with investors and the public.
Dec 01, 2017
Applied Clinical Trials
With the literal toss of a coin officially sending the EMA to Amsterdam post-Brexit, it's worth reflecting on what might have been if the decision went differently.
Oct 01, 2017
Applied Clinical Trials
New safety review of epilespy treatment puts spotlight on issues such as communication between regulators and prescribers.
Aug 01, 2017
Applied Clinical Trials
The European Health Data Network (EHDN) initiative kicks off—a challenging and resource-intensive effort designed to harmonize data analysis and conversion amid the push toward outcomes-focused healthcare in Europe.
Jun 01, 2017
Applied Clinical Trials
Several projects in works illustrate the importance of those unsung heroes in Europe's R&D engine room.
native1_300x100
lorem ipsum